Mostrar el registro sencillo del ítem

Artículo

dc.creatorMonferrer, E.es
dc.creatorSanegre, S.es
dc.creatorVieco-Martí, I.es
dc.creatorLópez-Carrasco, A.es
dc.creatorFariñas, F.es
dc.creatorVillatoro, A.es
dc.creatorCruz Merino, Luis de laes
dc.creatorÁlvaro Naranjo, T.es
dc.date.accessioned2022-11-23T15:44:08Z
dc.date.available2022-11-23T15:44:08Z
dc.date.issued2021-07-09
dc.identifier.issn2227-9059es
dc.identifier.urihttps://hdl.handle.net/11441/139731
dc.description.abstractThe study of cancer biology should be based around a comprehensive vision of the entire tumor ecosystem, considering the functional, bioenergetic and metabolic state of tumor cells and those of their microenvironment, and placing particular importance on immune system cells. Enhanced understanding of the molecular bases that give rise to alterations of pathways related to tumor development can open up new therapeutic intervention opportunities, such as metabolic regulation applied to immunotherapy. This review outlines the role of various oncometabolites and immunometabolites, such as TCA intermediates, in shaping pro/anti-inflammatory activity of immune cells such as MDSCs, T lymphocytes, TAMs and DCs in cancer. We also discuss the extraordinary plasticity of the immune response and its implication in immunotherapy efficacy, and highlight different therapeutic intervention possibilities based on controlling the balanced systems of specific metabolites with antagonistic functions.es
dc.formatapplication/pdfes
dc.format.extent18 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMetabolic reprogramminges
dc.subjectImmunometaboliteses
dc.subjectOncometaboliteses
dc.subjectRegulatory balancees
dc.titleImmunometabolism modulation in therapyes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.projectIDPI20/01107es
dc.relation.projectIDB2017/BMD-3733/IMMUNOTHERCAN-CMes
dc.relation.publisherversionhttps://www.mdpi.com/2227-9059/9/7/798es
dc.identifier.doi10.3390/biomedicines9070798es
dc.journaltitleBiomedicieses
dc.publication.volumen9es
dc.publication.issue7es
dc.publication.initialPage798es
dc.contributor.funderEuropean Regional Development Fundes
dc.contributor.funderComunidad de Madrides

FicherosTamañoFormatoVerDescripción
Immunometabolism...pdf1.235MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional